Corporate Board Profile
Tech Score: 75/100
3 mention(s) identify MONI MIYASHITA as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | 2022-03-25 | Since May 2019, she has served as the Chief Strategy Officer of Valo Health, LLC, a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence computation. Prior to Valo Health, from August 2015 to May 2019, she was a Partner at Innosight Consulting... Prior to McKinsey, she served as Vice President, Corporate Development at IBM Corporation, an information technology company, from 1998 to 2011. | Ms. Miyashita has extensive experience in technology and strategy roles, including Vice President of Corporate Development at IBM, a technology company, and Chief Strategy Officer at Valo Health, a technology company using AI in drug discovery, indicating software-related technical skills. |
| HALOZYME THERAPEUTICS, INC. | 2024-03-15 | She served as Vice President, Corporate Development at IBM Corporation, an information technology company, from 1998 to 2011. | She has extensive experience in technology and strategy, including serving as Vice President, Corporate Development at IBM Corporation, an information technology company, indicating technical and software-related skills. |
| HALOZYME THERAPEUTICS, INC. | 2025-03-18 | From 2011 to 2015, she was a Senior Advisor at McKinsey where she advised senior executive leadership teams on executing strategic M&A. Prior to McKinsey, she served as Vice President, Corporate Development at IBM, Inc., a multinational technology and consulting company, from 1998 to 2011. | Ms. Miyashita has extensive experience in technology and consulting, including serving as Vice President, Corporate Development at IBM, a multinational technology and consulting company, indicating software-related technical skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-03-25 | Since May 2019, she has served as the Chief Strategy Officer of Valo Health, LLC, a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence computation. Prior to Valo Health, from August 2015 to May 2019, she was a Partner at Innosight Consulting... Prior to McKinsey, she served as Vice President, Corporate Development at IBM Corporation, an information technology company, from 1998 to 2011. |
| 2023-03-24 | Since May 2019, she has served as the Chief Strategy Officer of Valo Health, LLC, a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence computation. Prior to Valo Health, she was a Partner at Innosight Consulting and Vice President, Corporate Development at IBM Corporation, an information technology company, from 1998 to 2011. She received her BS degree in marketing from the University of Colorado and her MBA from the University of Denver. |
| 2024-03-15 | She served as Vice President, Corporate Development at IBM Corporation, an information technology company, from 1998 to 2011. |
| 2025-03-18 | From 2011 to 2015, she was a Senior Advisor at McKinsey where she advised senior executive leadership teams on executing strategic M&A. Prior to McKinsey, she served as Vice President, Corporate Development at IBM, Inc., a multinational technology and consulting company, from 1998 to 2011. |
Data sourced from SEC filings. Last updated: 2026-02-03